Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 3

TABLE OF CONTENTS Volume 37, Issue 3 (February 2012) In this issue Commentary Review Original Articles Correspondence Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Read a FREE issue of Neuropsychopharmacology today! Neuropsychopharmacology – the official journal of the American College of Neuropsychopharmacology – is dedicated to publishing highly-ranked research in psychiatry, neuroscience, pharmacology and pharmacy. To learn more and to read a FREE sample issue online, visit www.neuropsychopharmacology.org.   Commentary Top High Times for Low-Frequency Stimulation as Endocannabinoids Engage in Hippocampal Long-Term Depression Sachin Patel Neuropsychopharmacology 2012 37: 583-585; 10.1038/npp.2011.275 Full Text Review Top Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review Carl L Hart, Caroline B Marvin, Rae Silver and Edward E Smith Neuropsychopharmacology 2012 37: 586-608; advance online publication, November 16, 2011; 10.1038/npp.2011.276 Abstract | Full Text Original Articles Top NMDA Receptors, mGluR5, and Endocannabinoids are Involved in a Cascade Leading to Hippocampal Long-Term Depression Yukitoshi Izumi and Charles F Zorumski Neuropsychopharmacology 2012 37: 609-617; advance online publication, October 12, 2011; 10.1038/npp.2011.243 Abstract | Full Text Effects of Chronic Marijuana Use on Brain Activity During Monetary Decision-Making Jatin G Vaidya, Robert I Block, Daniel S O'Leary, Laura B Ponto, Mohamed M Ghoneim and Antoine Bechara Neuropsychopharmacology 2012 37: 618-629; advance online publication, September 28, 2011; 10.1038/npp.2011.227 Abstract | Full Text Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers Boris B Quednow, Michael Kometer, Mark A Geyer and Franz X Vollenweider Neuropsychopharmacology 2012 37: 630-640; advance online publication, September 28, 2011; 10.1038/npp.2011.228 Abstract | Full Text Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials David P King, Sara Paciga, Eve Pickering, Neal L Benowitz, Laura J Bierut, David V Conti, Jaakko Kaprio, Caryn Lerman and Peter W Park Neuropsychopharmacology 2012 37: 641-650; advance online publication, November 2, 2011; 10.1038/npp.2011.232 Abstract | Full Text Opposite Effects of Amphetamine on Impulsive Action with Fixed and Variable Delays to Respond Scott J Hayton, Amanda C Maracle and Mary C Olmstead Neuropsychopharmacology 2012 37: 651-659; advance online publication, October 5, 2011; 10.1038/npp.2011.236 Abstract | Full Text Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial Joo-Cheol Shim, Do-Un Jung, Sung-Soo Jung, Young-Soo Seo, Deuk-Man Cho, Ji-Heon Lee, Sae-Woom Lee, Bo-Geum Kong, Je-Wook Kang, Min-Kyung Oh, Sang-Duk Kim, Robert P McMahon and Deanna L Kelly Neuropsychopharmacology 2012 37: 660-668; advance online publication, November 2, 2011; 10.1038/npp.2011.238 Abstract | Full Text Childhood Adversity Increases Risk for Nicotine Dependence and Interacts with α5 Nicotinic Acetylcholine Receptor Genotype Specifically in Males Pingxing Xie, Henry R Kranzler, Huiping Zhang, David Oslin, Raymond F Anton, Lindsay A Farrer and Joel Gelernter Neuropsychopharmacology 2012 37: 669-676; advance online publication, October 19, 2011; 10.1038/npp.2011.240 Abstract | Full Text The Effects of CACNA1C Gene Polymorphism on Spatial Working Memory in Both Healthy Controls and Patients with Schizophrenia or Bipolar Disorder Qiumei Zhang, Qiuge Shen, Zhansheng Xu, Min Chen, Lina Cheng, Jinguo Zhai, Huang Gu, Xin Bao, Xiongying Chen, Keqin Wang, Xiaoxiang Deng, Feng Ji, Chuanxin Liu, Jun Li, Qi Dong and Chuansheng Chen Neuropsychopharmacology 2012 37: 677-684; advance online publication, October 19, 2011; 10.1038/npp.2011.242 Abstract | Full Text Blockade of Dopamine D4 Receptors Attenuates Reinstatement of Extinguished Nicotine-Seeking Behavior in Rats Yijin Yan, Abhiram Pushparaj, Yann Le Strat, Islam Gamaleddin, Chanel Barnes, Zuzana Justinova, Steven R Goldberg and Bernard Le Foll Neuropsychopharmacology 2012 37: 685-696; advance online publication, October 26, 2011; 10.1038/npp.2011.245 Abstract | Full Text Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression Michael F Grunebaum, Steven P Ellis, Naihua Duan, Ainsley K Burke, Maria A Oquendo and J John Mann Neuropsychopharmacology 2012 37: 697-706; advance online publication, October 12, 2011; 10.1038/npp.2011.247 Abstract | Full Text Distinct Neurochemical Adaptations Within the Nucleus Accumbens Produced by a History of Self-Administered vs Non-Contingently Administered Intravenous Methamphetamine Kevin D Lominac, Arianne D Sacramento, Karen K Szumlinski and Tod E Kippin Neuropsychopharmacology 2012 37: 707-722; advance online publication, October 26, 2011; 10.1038/npp.2011.248 Abstract | Full Text Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT1A Receptor-Dependent Mechanism Lucila Kargieman, Maurizio S Riga, Francesc Artigas and Pau Celada Neuropsychopharmacology 2012 37: 723-733; advance online publication, October 19, 2011; 10.1038/npp.2011.249 Abstract | Full Text Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial Marcelo Queiroz Hoexter, Fábio Luis de Souza Duran, Carina Chaubet D'Alcante, Darin Dean Dougherty, Roseli Gedanke Shavitt, Antonio Carlos Lopes, Juliana Belo Diniz, Thilo Deckersbach, Marcelo Camargo Batistuzzo, Rodrigo Affonseca Bressan, Euripedes Constantino Miguel and Geraldo Filho Busatto Neuropsychopharmacology 2012 37: 734-745; advance online publication, October 26, 2011; 10.1038/npp.2011.250 Abstract | Full Text Developmental Influence of the Serotonin Transporter on the Expression of Npas4 and GABAergic Markers: Modulation by Antidepressant Treatment Gianluigi Guidotti, Francesca Calabrese, Francesca Auletta, Jocelien Olivier, Giorgio Racagni, Judith Homberg and Marco A Riva Neuropsychopharmacology 2012 37: 746-758; advance online publication, October 19, 2011; 10.1038/npp.2011.252 Abstract | Full Text ADORA2A Gene Variation, Caffeine, and Emotional Processing: A Multi-level Interaction on Startle Reflex Katharina Domschke, Agnieszka Gajewska, Bernward Winter, Martin J Herrmann, Bodo Warrings, Andreas Mühlberger, Katherina Wosnitza, Evelyn Glotzbach, Annette Conzelmann, Andrea Dlugos, Manfred Fobker, Christian Jacob, Volker Arolt, Andreas Reif, Paul Pauli, Peter Zwanzger and Jürgen Deckert Neuropsychopharmacology 2012 37: 759-769; advance online publication, October 19, 2011; 10.1038/npp.2011.253 Abstract | Full Text Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex David JG Watson, Florence Loiseau, Manuela Ingallinesi, Mark J Millan, Charles A Marsden and Kevin CF Fone Neuropsychopharmacology 2012 37: 770-786; advance online publication, October 26, 2011; 10.1038/npp.2011.254 Abstract | Full Text Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus Christoph K Thoeringer, Kathrin Henes, Matthias Eder, Maik Dahlhoff, Wolfgang Wurst, Florian Holsboer, Jan M Deussing, Sven Moosmang and Carsten T Wotjak Neuropsychopharmacology 2012 37: 787-796; advance online publication, October 26, 2011; 10.1038/npp.2011.256 Abstract | Full Text Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation Andreas Menke, Katharina Domschke, Darina Czamara, Torsten Klengel, Johannes Hennings, Susanne Lucae, Bernhard T Baune, Volker Arolt, Bertram Müller-Myhsok, Florian Holsboer and Elisabeth B Binder Neuropsychopharmacology 2012 37: 797-807; advance online publication, October 26, 2011; 10.1038/npp.2011.257 Abstract | Full Text α- and β-Adrenergic Receptors Differentially Modulate the Emission of Spontaneous and Amphetamine-Induced 50-kHz Ultrasonic Vocalizations in Adult Rats Jennifer M Wright, May R S Dobosiewicz and Paul B S Clarke Neuropsychopharmacology 2012 37: 808-821; advance online publication, October 26, 2011; 10.1038/npp.2011.258 Abstract | Full Text Modulation of Fronto-Cortical Activity by Modafinil: A Functional Imaging and Fos Study in the Rat Alessandro Gozzi, Valeria Colavito, Paul F Seke Etet, Dino Montanari, Silvia Fiorini, Stefano Tambalo, Angelo Bifone, Gigliola Grassi Zucconi and Marina Bentivoglio Neuropsychopharmacology 2012 37: 822-837; advance online publication, November 2, 2011; 10.1038/npp.2011.260 Abstract | Full Text Regional Cortical Thickness and Subcortical Volume Changes Are Associated with Cognitive Impairments in the Drug-Naive Patients with Late-Onset Depression Hyun Kook Lim, Won Sang Jung, Kook Jin Ahn, Wang Youn Won, Changtae Hahn, Seung Yup Lee, InSeong Kim and Chang Uk Lee Neuropsychopharmacology 2012 37: 838-849; advance online publication, November 2, 2011; 10.1038/npp.2011.264 Abstract | Full Text Correspondence Top Mathematical Coupling and the True Role of Baseline Severity in Acute Mania Trials Konstantinos N Fountoulakis and Dimitrios Kontis Neuropsychopharmacology 2012 37: 850; 10.1038/npp.2011.234 Full Text Advertisement Ensure your access to Neuropsychopharmacology If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now.   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.